Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Both ABIVERTINIB Covid studies used a 9-point ordinal scale as follows: (0) nonhospitalized and no clinical or virological evidence of infection; (1) nonhospitalized and no limitation on activities; (2) nonhospitalized, but with limitation on activities; (3) hospitalized, but not requiring supplemental oxygen; (4) hospitalized and on oxygen via mask or nasal prongs; (5) hospitalized, on noninvasive ventilation or high-flow oxygen or pressure support ventilation in weaning mode; (6) hospitalized, intubated and on MV; (7) hospitalized on MV and additional organ support (renal replacement therapy, vasoactive drugs or extracorporeal membrane oxygenation), and (8) dead.
Sorrento has trials underway for each stage of COVID. Just guessing but could be...
COVIDROPS for status 1-3.
ABIVERTINIB for status 4-5.
COVI-MSC for status 5-7.
And how about ABIVERTINIB and COVI-MSC combinations?